Purpose: Clinical stage of gastric cancer is currently assessed by computed tomography. Accurate clinical staging is important for the tailoring of therapy. This study evaluated the accuracy of clinical N staging using stomach protocol computed tomography. Materials and Methods: Between March 2004 and November 2012, 171 patients with gastric cancer underwent preoperative stomach protocol computed tomography (Jeju National University Hospital; Jeju, Korea). Their demographic and clinical characteristics were reviewed retrospectively. Two radiologists evaluated cN staging using axial and coronal computed tomography images, and cN stage was matched with pathologic results. The diagnostic accuracy of stomach protocol computed tomography for clinical N staging and clinical characteristics associated with diagnostic accuracy were evaluated. Results: The overall accuracy of stomach protocol computed tomography for cN staging was 63.2%. Computed tomography images of slice thickness 3.0 mm had a sensitivity of 60.0%; a specificity of 89.6%; an accuracy of 78.4%; and a positive predictive value of 78.0% in detecting lymph node metastases. Underestimation of cN stage was associated with larger tumor size (P<0.001), undifferentiated type (P=0.003), diffuse type (P=0.020), more advanced pathologic stage (P<0.001), and larger numbers of harvested and metastatic lymph nodes (P<0.001 each). Tumor differentiation was an independent factor affecting underestimation by computed tomography (P=0.045). Conclusions: Computed tomography with a size criterion of 8 mm is highly specific but relatively insensitive in detecting nodal metastases. Physicians should keep in mind that computed tomography may not be an appropriate tool to detect nodal metastases for choosing appropriate treatment.
Introduction
Although the incidence of gastric cancer has been declining in most industrialized nations, it remains the most prevalent form of cancer in East Asian countries. 1, 2 In Korea, the incidence of early gastric cancer (EGC) has increased due to improvements in diagnostic methods and changes in the concept of routine health examinations. 2 Early detection has led to the introduction of various tailored and limited therapies for EGC, enhancing survival outcomes. 3 Less invasive treatment methods of resection include endoscopic and laparoscopic treatment. 3, 4 Accurate preoperative clinical staging has therefore become very important in determining treatment plans and predicting patient outcomes.
The most important prognostic factors in gastric cancer include depth of invasion, lymph node (LN) involvement, and distant metastases. 5, 6 In addition, adequate lymphadenectomy is important in predicting treatment outcomes. 7 Patients without LN metastasis should be spared aggressive procedures to improve their quality of life. Therefore, preoperative knowledge of LN status would be helpful in planning the optimal extent of gastric resection and lymphadenectomy. This study was designed to assess the diagnostic accuracy of stomach protocol computed tomography (S-CT) for cN staging. Because undertreatment can be caused by underestimation of preoperative cN staging, the risk factors associated with underestimation of LN status were analyzed.
Materials and Methods Patients examined by conventional computed tomography (CT)
without the stomach protocol were excluded, as were patients who underwent endoscopic resection. Endoscopic resection was indicated in our hospital for patients with tumors confined to the mucosa, ＜2 cm in diameter; classified as well or moderately differentiated adenocarcinoma; and with no evidence of LN or distant metastases on abdominal CT or endoscopic ultrasonography (EUS). A total of 171 patients, who underwent S-CT preoperatively within 3 weeks from the operation, were included in this study. The specimens obtained by surgical resection were histopathologically evaluated, and the findings were used as reference standards for N staging.
Histologic staging was based on the 7th edition of American Joint
Committee on Cancer (AJCC) staging system of gastric cancer. In addition, each LN tier was classified according to Japanese Gastric Cancer Association guidelines. 4 The authors' criteria for cN staging were adopted after review of published articles. [8] [9] [10] Most of these patients were discussed in pre- cN stage on S-CT was determined using the following criteria:
LN metastasis was considered present if the short-axis diameter of any LNs was ≥8 mm ( Fig. 1 and 2) , if there was a cluster of three or more perilesional nodes regardless of size, or if the LNs showed 
Statistical analysis
Quantitative results are expressed as mean±standard deviation. Ordinal variables were compared using independent t-tests or ANOVA with Tukey's test, and categorical variables were compared using Fisher's exact tests. Multivariate logistic regression analysis was used to determine the factors leading to underestimation. All statistical analyses were performed using the PASW Statistics 18.0 software program (IBM Co., Armonk, NY, USA), with P-values less than 0.05 considered statistically significant.
Results
The clinical and pathologic characteristics of the 171 included patients are summarized in Table 1 The size of this lymph node was 8.3 mm in short diameter on axial image. However, it was no evidence of metastasis by pathological examination. When clinical staging with S-CT for LN metastasis was compared with histological nodal staging in patients with EGC, the overall accuracy for detailed cN staging was found to be 81.6%
( 17 and MDCT with multi-planar reformatted and 3D images has improved the accuracy of T and N staging in patients with gastric cancer. 8, 9 However, most investigations have found that the sensitivity and specificity of MDCT ranged widely from 60% to 90%. 13, 16 When the criteria defined all identifiable LNs as metastatic LNs, a high sensitivity and Values are presented as number (%).
a relatively low specificity were revealed. 18 Whereas, a relatively low sensitivity and a high specificity were revealed in the criteria of size more than 8 mm. 8, 16 The less than satisfactory diagnostic accuracy of MDCT for cN staging indicates the need to develop imaging modalities with both high sensitivity and high specificity.
Although cN staging by MDCT has been based on the size, at- Values are presented as mean±standard deviation or number (%). S-CT = stomach protocol computed tomography; U = upper 1/3; M = middle 1/3; L = lower 1/3; Sig. = significance; Exp (B) = odds ratio; CI = confidence interval.
tenuation values, and shapes of LNs, the criteria have varied. 8, 9, [12] [13] [14] [15] [16] [17] These discrepancies are likely due to the high frequency of microscopic tumor involvement in small-sized LNs and the poor differentiation between reactive and metastatic involvement of largesized LNs. For example, metastases have been found in 22.9% of undetected LNs and in about 60% of LNs ＞10 mm in size; furthermore, since at least 50% of the detected LNs were oval-shaped, shape alone was not a specific criterion to define infiltration. 19 Another histologic study investigating the correlation between LN size and metastatic infiltration found that benign LNs of clinically relevant size are significantly more frequently observed in gastric cancer patients than in asymptomatic healthy individuals, as well as being more frequent in advanced than in EGC. 20 These findings indicate that the diagnostic accuracy of MDCT for cN staging can be influenced by the cN stage criteria.
We found that CT images of slice thickness 3.0 mm could diagnose the presence of LN metastasis with a sensitivity of 60.0%, a specificity of 89.6%, an accuracy of 78.4%, and a positive predictive value of 78.0%. However, its sensitivity and specificity for the presence of LN metastasis in patients with EGC were 35.7% and 91.0%, respectively. Our MDCT results were similar to those of previous reports, except that we observed lower sensitivity. 13, 16 Yan et al. 21 demonstrated that the diagnostic sensitivity of MDCT for determining LN metastasis of gastric carcinoma in patients with ≥4
metastatic LNs was higher than that in those with ＜4 (94.9% vs.
73.1%, P=0.000). We speculate that this low sensitivity results from high proportion (85.7%) of N1 among pN stages with LN metastasis in present study. In addition, our criteria may be too strict for EGC frequently with small or normal-sized metastatic nodes.
S-CT had similar diagnostic accuracy among LN tiers, except that its sensitivity and specificity for LNs 3 and 4 were lower than for other LN tiers. LN tiers 3 and 4 are wider than the other LN tiers, suggesting the possibility of overlap with the gastric wall.
S-CT had an overall accuracy of 56.5% for cT stage and 63.2%
for cN stage in our institute. 11 Differentiation between EGC and AGC is important in deciding the extent of surgery. CT images could diagnose EGC lesions with a sensitivity of 90.3%, a specificity of 83.1%, an accuracy 87.5%, and a positive predictive value of 89.4%. 11 Therefore, S-CT is highly specific but relatively insensitive for detecting nodal metastases, but is more sensitive in predicting invasion depth beyond the gastric muscular layer in our institute. In conclusion, MDCT is highly specific but relatively insensitive in detecting nodal metastases in our criteria. Although the diagnostic accuracy of cN staging by MDCT is not poor, its sensitivity of 60% presents problems when using it to make therapeutic decisions. Improvements in imaging equipment and techniques will be essential in overcoming the drawbacks of this method, and rigorous criteria should be developed to improve the clinical usefulness of MDCT.
